These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 26765484

  • 1. Soluble Fas/FasL ratio as a marker of vasculopathy in children and adolescents with sickle cell disease.
    Adly AA, Ismail EA, Andrawes NG, Mahmoud MM, Eladawy R.
    Cytokine; 2016 Mar; 79():52-8. PubMed ID: 26765484
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA, Adly AA, Ismail EA, Darwish YW, Ali Zedan M.
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJ, Jaber BL.
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [Abstract] [Full Text] [Related]

  • 8. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
    Tantawy AA, Adly AA, Ismail EA.
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
    [Abstract] [Full Text] [Related]

  • 9. [Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].
    Jun EJ, Han JY, Sun HS.
    Korean J Hepatol; 2006 Dec; 12(4):507-14. PubMed ID: 17237628
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunological role of CD4+CD28null T lymphocytes, natural killer cells, and interferon-gamma in pediatric patients with sickle cell disease: relation to disease severity and response to therapy.
    ElAlfy MS, Adly AAM, Ebeid FSE, Eissa DS, Ismail EAR, Mohammed YH, Ahmed ME, Saad AS.
    Immunol Res; 2018 Aug; 66(4):480-490. PubMed ID: 29926339
    [Abstract] [Full Text] [Related]

  • 12. sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome.
    Doughty L, Clark RS, Kaplan SS, Sasser H, Carcillo J.
    Pediatr Res; 2002 Dec; 52(6):922-7. PubMed ID: 12438671
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.
    Vincent FB, Kandane-Rathnayake R, Koelmeyer R, Harris J, Hoi AY, Mackay F, Morand EF.
    Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32546562
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alteration of sFAS and sFAS ligand expression during canine visceral leishmaniosis.
    Perosso J, Silva KL, Ferreira SÍ, Avanço SV, dos Santos PS, Eugênio Fde R, de Almeida BF, de Lima VM.
    Vet Parasitol; 2014 Oct 15; 205(3-4):417-23. PubMed ID: 25260330
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.